LA MESA, Calif., Dec. 16, 2004 (PRIMEZONE) -- Nicodrops, Inc. (Pink Sheets:NCDP), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, today announced a manufacturing relationship with Quigley Manufacturing, Inc. to produce the company's all natural herb lozenge. In addition, Quigley will handle fulfillment and distribution for Nicodrops.
"We now have in place the ability to meet demand for our nicodrops product in a timely and cost effective fashion with Quigley, an experienced confectionery manufacturing firm that is very familiar with producing similar products," said Christopher Calpito, president and CEO of Nicodrops, Inc. "Quigley understands the fulfillment and distribution process on both a national and worldwide level. Their superior manufacturing expertise will be key for us to launch our product on a major scale."
Calpito said Nicodrops is positioning the company for success. "Our company is fully funded at this time, has little overhead, and we believe we can generate profit margins of 60 percent or higher since we have come out of research and development phase and are now aggressively seeking to generate revenues on behalf of our shareholders," according to Calpito.
About Nicodrops:
Nicodrops Inc., headquartered in La Mesa, CA, has developed the world's first drug free, non-nicotine product which allows smokers to give up their habit faster and at a lower cost than their major competitors without the adverse effects of nicotine. Nicodrops is an all-natural herb lozenge which helps to calm the nervous anxiety that is brought on by nicotine addiction. The company's lozenge products are based on patent protected proprietary technology which offers a safer alternative to all other nicotine based products in the marketplace today.